With absolute or relative exogenous insulin excess, insulin activity is dictated by the pharmacokinetic characteristics of the drug
The unmodified parent compound, recombinant human IGF-1 (mecasermin), is FDA-approved (2005) for severe primary IGF-1 deficiency and Laron syndrome in pediatric patients, but the modified LR3 analog itself has not been advanced into clinical development
Sustainable weight management still depends on diet, physical activity, sleep, and treatment of contributing conditions when present
At 10mg/ml, 2.5mg equals 25 units
Such personalized approaches can increase satisfaction and treatment success
Always check with your prescriber before resuming, especially if your diet, weight, or other medications have changed." He also emphasises the importance of monitoring your bodys response beyond the scale